Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Fingolimod

EU orphan designation number: EU/3/09/718   
Active ingredient: Fingolimod
Indication: Treatment of chronic inflammatory demyelinating polyneuropathy
Sponsor: Novartis Europharm Limited
Frimley Business Park, Camberley GU16 7SR, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/02/2010 Centralised Orphan - Designation EMEA/OD/107/09 (2010)793 of 02/02/2010
29/08/2014 Centralised Orphan - Change of address